Treatment of age related macular degeneration (AMD) currently and in the past

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain. AMD is an irreparable disorder...

Full description

Bibliographic Details
Main Authors: Klaudia Brożyna, Jędrzej Tkaczyk, Katarzyna Baltaziak, Krystian Ciechański, Lucyna Baltaziak, Robert Rejdak
Format: Article
Language:English
Published: Kazimierz Wielki University 2018-08-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860
id doaj-ad324b09e80a4497a21131742dbe3aad
record_format Article
spelling doaj-ad324b09e80a4497a21131742dbe3aad2020-11-24T23:48:47ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062018-08-018885086110.5281/zenodo.14030115371Treatment of age related macular degeneration (AMD) currently and in the pastKlaudia Brożyna0Jędrzej Tkaczyk1Katarzyna Baltaziak2Krystian Ciechański3Lucyna Baltaziak4Robert Rejdak5Medical University of LublinStudent`s Research Group at the Department of Epidemiology and Clinical Research Methodology, Medical University of LublinStudent`s Research Group at the Clinical Department of Ophthalmology, Medical University of LublinStudent`s Research Group at the Department of Epidemiology and Clinical Research Methodology, Medical University of LublinMedical University of LublinClinical Department of General Ophthalmology, Medical University of LublinAge-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain. AMD is an irreparable disorder, which mostly occurs among people after 50. Nowadays the pathogenesis of AMD is still not entirely clarified, however this disorder has multifactor background, which include interactions between genetic and environmental factors. AMD is divided into two forms: exudative (“wet”) and nonexudative (“dry”). The treatment of age-related macular degeneration depends on the stage of the disease progression. One of the first methods of treatment of exudative AMD was laser photocoagulation with argon laser. Currently, this kind of treatment is used in certain cases of neovascularization in extrafoveal area. Next elderly method of therapy of AMD was a photodynamic therapy (PDT) at year 2000. The treatment consist in intravenous injection of verteporfin and a laser at the same time. At 2002 was in use transpupillary thermotherapy (TTT). Last few years for treatment AMD is used antagonist of vascular endothelial growth factor (VEGF). We distinguish: pegatanib, ranibizumab, bevacizumab and aflibercept. Nowadays all of available methods do not eliminate causes of that disorder and in this connection currently treatment is still symptomatic. Apart from every mentioned method above, nutritional therapy is also essential and it decrease the risk of progression of AMD. The diet should contain products full of vitamin C,E, beta carotene, zinc and copper.http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860amd, treatment, pathogenesis
collection DOAJ
language English
format Article
sources DOAJ
author Klaudia Brożyna
Jędrzej Tkaczyk
Katarzyna Baltaziak
Krystian Ciechański
Lucyna Baltaziak
Robert Rejdak
spellingShingle Klaudia Brożyna
Jędrzej Tkaczyk
Katarzyna Baltaziak
Krystian Ciechański
Lucyna Baltaziak
Robert Rejdak
Treatment of age related macular degeneration (AMD) currently and in the past
Journal of Education, Health and Sport
amd, treatment, pathogenesis
author_facet Klaudia Brożyna
Jędrzej Tkaczyk
Katarzyna Baltaziak
Krystian Ciechański
Lucyna Baltaziak
Robert Rejdak
author_sort Klaudia Brożyna
title Treatment of age related macular degeneration (AMD) currently and in the past
title_short Treatment of age related macular degeneration (AMD) currently and in the past
title_full Treatment of age related macular degeneration (AMD) currently and in the past
title_fullStr Treatment of age related macular degeneration (AMD) currently and in the past
title_full_unstemmed Treatment of age related macular degeneration (AMD) currently and in the past
title_sort treatment of age related macular degeneration (amd) currently and in the past
publisher Kazimierz Wielki University
series Journal of Education, Health and Sport
issn 2391-8306
publishDate 2018-08-01
description Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain. AMD is an irreparable disorder, which mostly occurs among people after 50. Nowadays the pathogenesis of AMD is still not entirely clarified, however this disorder has multifactor background, which include interactions between genetic and environmental factors. AMD is divided into two forms: exudative (“wet”) and nonexudative (“dry”). The treatment of age-related macular degeneration depends on the stage of the disease progression. One of the first methods of treatment of exudative AMD was laser photocoagulation with argon laser. Currently, this kind of treatment is used in certain cases of neovascularization in extrafoveal area. Next elderly method of therapy of AMD was a photodynamic therapy (PDT) at year 2000. The treatment consist in intravenous injection of verteporfin and a laser at the same time. At 2002 was in use transpupillary thermotherapy (TTT). Last few years for treatment AMD is used antagonist of vascular endothelial growth factor (VEGF). We distinguish: pegatanib, ranibizumab, bevacizumab and aflibercept. Nowadays all of available methods do not eliminate causes of that disorder and in this connection currently treatment is still symptomatic. Apart from every mentioned method above, nutritional therapy is also essential and it decrease the risk of progression of AMD. The diet should contain products full of vitamin C,E, beta carotene, zinc and copper.
topic amd, treatment, pathogenesis
url http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860
work_keys_str_mv AT klaudiabrozyna treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
AT jedrzejtkaczyk treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
AT katarzynabaltaziak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
AT krystianciechanski treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
AT lucynabaltaziak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
AT robertrejdak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast
_version_ 1725484558253555712